The reigning champions in the battle of the bulge are Novo Nordisk A/ V NYSE: NVO with its Semaglutide medications Ozempic and Wegovy, and Eli Lilly & Co
For example, in the STEP 1 trial, participants receiving semaglutide 2.4 mg weekly showed improvements in insulin sensitivity markers that correlated with the degree of weight loss achieved after 68 weeks of treatment
The abdomen is an FDA-approved injection site for these medications, offering accessibility and consistent subcutaneous tissue
Thats why Ozempic and muscle loss has become a growing concern, especially as more people use GLP-1 medications that suppress appetite
They don't cause jitters and are simple to ingest
Before IVF or IUI, women often receive an hCG trigger shot, which can make a pregnancy test appear positive